September « 2011 « Return On Focus | https://returnonfocus.com | Return On Focus

What We Think

EVIDENCE bLOG

Pre-Launch Unbranded Communication Follows Desired Launch Communication Platform

Biopharma has unbranded message development backwards. There I said it! How in the world can you define your unbranded message platform if you don’t know where you’re headed with your brand message platform? Market education or development activities aren’t altruistic. These activities are supposed to educate the market in a way that helps the target audience understand how to appropriately use and differentiate your product quickly after launch.

Communication Platform AnatomyIt has been our experience in applying Evidence-Based Marketing to communication development over the past 5 years that the identification of key educational messaging prescripts is essential for accelerating launch uptake. Educational prescripts are basically the unbranded messages that serve to quicken internalization of a promotional story and can be linked to intensified product adoption at launch. Quantitative evidence supports this.

Recent work that we did related to a Client launch of a forecasted billion-dollar brand demonstrated (with a P value) that internalization of key educational prescripts prior to launch, not only increased onset of prescribing, but depth of prescribing as well. A subsequent study with early adopters provided additional evidence and validation of the criticality of educational prescripts in launch platform development. Uncovering these prescripts and incorporating them into the launch communication platform is essential for success in today’s market.

With educational prescripts in hand, only then are you able to define and invest in appropriate unbranded pre-marketing activities!

The Potential Perils of Over-Relying on Expert Advice — A Visionary Tale

Today’s brand director launching the next big advance in science too often circulates exclusively among rarified air. What I mean is that their views about the market, prescribers, and patients are almost exclusively shaped by the 4-6 key opinion leaders (KOL) who specialize in their target market. Over reliance on KOL input to shape your clinical and promotional plans is fraught with danger. Let me give you a case study to illustrate.

A company provided unfettered access to leading KOLs in the field for a new product in advance of full-scale roll out. Each KOL was provided a concierge from the home office to ensure the expert was detailed on the product through and through . . . plus each expert had 24-hours access for help in using the product.

Here was the product feedback from experts verbatim:

“An utter disappointment and abysmal failure”
“I’m genuinely baffled by why we might need it”
” . . . great it is not”
“My god, am I underwhelmed”

As it turns out, the problem here was not really the product. It was actually that the “experts” who took part in this controlled test were constrained by their own realities. They were not able to think of what could be possible with this new product, only what currently was possible. Thankfully, the company had the courage and foresight to recognize this limitation and they launched anyway.

The product you ask? Apple iPad2.

*Adpated from David Pogue article appearing in NYTimes on March 9, 2011.

Follow us on
Pinterest Twitter slideshare
Contact Us
XXX

Powered by WordPress